These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 31760834

  • 1. The Effect of Blood Transfusion on Growth of Patients with Hb E/β-Thalassemia.
    Chuansumrit A, Sirachainan N, Kitpoka P, Kadegasem P, Songdej D, Sasanakul W, Wongwerawattanakoon P.
    Hemoglobin; 2019; 43(4-5):264-272. PubMed ID: 31760834
    [Abstract] [Full Text] [Related]

  • 2. Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients under different treatment regimens.
    Viprakasit V, Tanphaichitr VS, Mahasandana C, Assteerawatt A, Suwantol L, Veerakul G, Kankirawatana S, Pung-Amritt P, Suvatte V.
    J Med Assoc Thai; 2001 Jul; 84(7):929-41. PubMed ID: 11759973
    [Abstract] [Full Text] [Related]

  • 3. The Prevalence of HBB Mutations among the Transfusion-Dependent and Non Transfusion-Dependent Hb E/β-Thalassemia Children in a Tertiary Center of West Bengal, India.
    Saha J, Panja A, Nayek K.
    Hemoglobin; 2021 May; 45(3):157-162. PubMed ID: 34060430
    [Abstract] [Full Text] [Related]

  • 4. Growth velocity in transfusion dependent prepubertal thalassemia patients: results from a thalassemia center in Malaysia.
    Hamidah A, Arini MI, Zarina AL, Zulkifli SZ, Jamal R.
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):900-5. PubMed ID: 19058587
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of low bone mass among adolescents with nontransfusion-dependent hemoglobin E/β-thalassemia and its relationship with anemia severity.
    Nakavachara P, Petchkul J, Jeerawongpanich K, Kiattisakthavee P, Manpayak T, Netsakulnee P, Chaichanwattanakul K, Pooliam J, Srichairatanakool S, Viprakasit V.
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28801997
    [Abstract] [Full Text] [Related]

  • 6. Iron overload and iron-chelating therapy in hemoglobin E-beta thalassemia.
    Olivieri NF, De Silva S, Premawardena A, Sharma S, Viens AM, Taylor CM, Brittenham GM, Weatherall DJ.
    J Pediatr Hematol Oncol; 2000 Jan; 22(6):593-7. PubMed ID: 11132236
    [Abstract] [Full Text] [Related]

  • 7. Clinical and Molecular Characteristics of Non-Transfusion-Dependent Thalassemia in Kuwait.
    Adekile AD, Azab AF, Al-Sharida SI, Al-Nafisi BA, Akbulut N, Marouf RA, Mustafa NY.
    Hemoglobin; 2015 Jan; 39(5):320-6. PubMed ID: 26076396
    [Abstract] [Full Text] [Related]

  • 8. Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC.
    Soliman AT, Yassin MA, De Sanctis V.
    Acta Biomed; 2018 Feb 16; 89(2-S):27-32. PubMed ID: 29451226
    [Abstract] [Full Text] [Related]

  • 9. The correlation of α-globin gene mutations and the XmnI polymorphism with clinical severity of Hb E/β-thalassemia.
    Charoenkwan P, Teerachaimahit P, Sanguansermsri T.
    Hemoglobin; 2014 Feb 16; 38(5):335-8. PubMed ID: 25238043
    [Abstract] [Full Text] [Related]

  • 10. New therapeutic targets in transfusion-dependent and -independent thalassemia.
    Cappellini MD, Motta I.
    Hematology Am Soc Hematol Educ Program; 2017 Dec 08; 2017(1):278-283. PubMed ID: 29222267
    [Abstract] [Full Text] [Related]

  • 11. Blood transfusion from a Hb E trait donor can affect β-thalassemia diagnosis.
    Pornprasert S, Jaiping K.
    Hemoglobin; 2014 Dec 08; 38(4):295-8. PubMed ID: 24940968
    [Abstract] [Full Text] [Related]

  • 12. Vascular and hemostatic alterations associated with pulmonary hypertension in β-thalassemia hemoglobin E patients receiving regular transfusion and iron chelation.
    Uaprasert N, Satitthummanid S, Akkawat B, Sutcharitchan P, Rojnuckarin P.
    Thromb Res; 2019 Feb 08; 174():104-112. PubMed ID: 30584959
    [Abstract] [Full Text] [Related]

  • 13. Effect of different treatment regimes on linear growth and final height in beta-thalassaemia major.
    De Sanctis V, Katz M, Vullo C, Bagni B, Ughi M, Wonke B.
    Clin Endocrinol (Oxf); 1994 Jun 08; 40(6):791-8. PubMed ID: 8033371
    [Abstract] [Full Text] [Related]

  • 14. Differences in longitudinal growth patterns of children and adolescents with transfusion-dependent hemoglobin E/β-thalassemia and those achieving successful hematopoietic stem-cell transplantation.
    Jitpirasakun S, Pooliam J, Sriwichakorn C, Sanpakit K, Nakavachara P.
    Int J Hematol; 2022 Apr 08; 115(4):575-584. PubMed ID: 35192188
    [Abstract] [Full Text] [Related]

  • 15. Clinical characteristics, laboratory features and genetic profile of hemoglobin E (HBB:c.79 G > A)/β (nucleotide -28 A > G) (HBB:c.-78 A > G) -thalassemia subjects identified from community- and hospital-recruited cohorts.
    Chumnumsiriwath P, Charoenporn P, Jermnim S, Suannum P, Samaisombat M, Tapprom A, Deoisares R, Wong P.
    Blood Cells Mol Dis; 2024 Nov 08; 109():102883. PubMed ID: 39154456
    [Abstract] [Full Text] [Related]

  • 16. Incidence of ototoxicity in pediatric patients with transfusion-dependent thalassemia who are less well-chelated by mono- and combined therapy of iron chelating agents.
    Tanphaichitr A, Kusuwan T, Limviriyakul S, Atipas S, Pooliam J, Sangpraypan T, Tanphaichitr VS, Viprakasit V.
    Hemoglobin; 2014 Nov 08; 38(5):345-50. PubMed ID: 25051423
    [Abstract] [Full Text] [Related]

  • 17. Challenges in chronic transfusion for patients with thalassemia.
    Lal A.
    Hematology Am Soc Hematol Educ Program; 2020 Dec 04; 2020(1):160-166. PubMed ID: 33275743
    [Abstract] [Full Text] [Related]

  • 18. 2021 update on clinical trials in β-thalassemia.
    Musallam KM, Bou-Fakhredin R, Cappellini MD, Taher AT.
    Am J Hematol; 2021 Nov 01; 96(11):1518-1531. PubMed ID: 34347889
    [Abstract] [Full Text] [Related]

  • 19. Hb E-β-Thalassemia in Five Indian States.
    Italia K, Dabke P, Sawant P, Nadkarni A, Ghosh K, Colah RB.
    Hemoglobin; 2016 Sep 01; 40(5):310-315. PubMed ID: 27623935
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of decitabine as hemoglobin F inducer in HbE/β-thalassemia.
    Kalantri SA, Ray R, Chattopadhyay A, Bhattacharjee S, Biswas A, Bhattacharyya M.
    Ann Hematol; 2018 Sep 01; 97(9):1689-1694. PubMed ID: 29740685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.